Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Copyright Notice

Pfizer SWOT

Pfizer—a SWOT Analysis

Strengths

Pfizer is one of the world's leading research pharmaceutical companies and also one of the world's most pr*****itable *****. It has a well-respected n*****me known all over the world and commands some of the top *****, advertising, financial, and marketing talent. It produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even the American Heart Association recommends ***** use of ***** such as Lipitor to reduce cholesterol when diet and exercise fail to reduce this common health problem. High cholesterol as a common ***** problem is only likely to *****cre*****e with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied ***** Lipitor" which is dangerous for the ***** in ***** future as Lipitor's patent will expire ***** several years, ***** means it ***** face competition from cheaper, generic drugs (*****, 2007). Pfizer's reputation has also been tainted by ***** association with Celebrex, a pain medication that has been tied to increased risk of heart problems, in comparison to over-the-counter painkillers. The prominence ***** the Pfizer advertising campaign for this drug, followed by its rapid fall from grace undoubtedly damaged the company's trusted name.

***** ***** manufactures Zoloft, an antidepressant that was widely criticized for ***** over-prescription to teenager, and possibly causing ***** suicidal thoughts in ***** population. The company website now states that the drug is not advised for people under the age of 17. Antidepressants and 'lifestyle' ********** like Viagra have come under *****creased media scrutiny ***** used as examples of the over-prescription of ***** in the American healthcare system in general. Healthcare in America is growing more and more expensive, and insurance companies are being pressured ***** cut costs, including scaling back how much they pay for drugs.

Now, Exubera, "the first ***** so far only commercially available inhaled-insulin diabetes treatment," ***** on ***** verge ***** turning into an "expensive failure" as Pfizer "***** been dogged by questions about its safety, cost and convenience" (Berenson, 2007).

Opportunities

According to the Pfizer press release section of its website, discomfort associated ***** fibromyaglia, a ***** chronic pain condition, has ***** s*****n to be significantly reduced by a new drug developed by Pfizer c*****lled Lyrica, "according to study results presented ***** at the ***** Academy of Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer ***** also developed a new AIDS drug called Maraviroc, which is likely to considerably improve and extend the life ***** AIDS patients who take the *****, according to researchers at the University of Pittsburg and Columbia University (Altman & Pollock, *****).

Threats

Both Merck ***** Schering-Plough, ***** of Pfizer's greatest rivals, plan to combine forces and develop a medicine ***** rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit ***** market when ***** patent expires in a few *****" ("Merck and Schering-Plough Plan A*****her Cholesterol Drug,"

. . . . [END OF THESIS PAPER PREVIEW]

Download complete paper (and others like it)    |    Order a one-of-a-kind, custom paper

© 2001–2017   |   Term Papers about Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Term Paper Writing